Literature DB >> 11602572

Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response.

Y Yuan1, Z Shen.   

Abstract

The BRCA2 tumor suppressor plays significant roles in DNA damage response. The human actin binding protein filamin-1 (hsFLNa, also known as ABP-280) participates in orthogonal actin network, cellular stress responses, signal transduction, and cell migration. Through a yeast two-hybrid system, an in vitro binding assay, and in vivo co-immunoprecipitations, we identified an interaction between BRCA2 and hsFLNa. The hsFLNa binding domain of BRCA2 was mapped to an internal conserved region, and the BRCA2-interacting domain of hsFLNa was mapped to its C terminus. Although hsFLNa is known for its cytoplasmic functions in cell migration and signal transduction, some hsFLNa resides in the nucleus, raising the possibility that it participates in DNA damage response through a nuclear interaction with BRCA2. Lack of hsFLNa renders a human melanoma cell line (M2) more sensitive to several genotoxic agents including gamma irradiation, bleomycin, and ultraviolet-c light. These results suggest that BRCA2/hsFLNa interaction may serve to connect cytoskeletal signal transduction to DNA damage response pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602572     DOI: 10.1074/jbc.M102557200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Filamins in mechanosensing and signaling.

Authors:  Ziba Razinia; Toni Mäkelä; Jari Ylänne; David A Calderwood
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

2.  Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription.

Authors:  Wensheng Deng; Cesar Lopez-Camacho; Jen-Yang Tang; Daniel Mendoza-Villanueva; Apolinar Maya-Mendoza; Dean A Jackson; Paul Shore
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis.

Authors:  Gourish Mondal; Matthew Rowley; Lucia Guidugli; Jianmin Wu; Vernon S Pankratz; Fergus J Couch
Journal:  Dev Cell       Date:  2012-07-05       Impact factor: 12.270

4.  Ultrastructural localization of actin and actin-binding proteins in the nucleus.

Authors:  Hana Dingová; Jana Fukalová; Miloslava Maninová; Vlada V Philimonenko; Pavel Hozák
Journal:  Histochem Cell Biol       Date:  2008-11-28       Impact factor: 4.304

5.  The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair.

Authors:  Huimei Lu; Xu Guo; Xiangbing Meng; Jingmei Liu; Chris Allen; Justin Wray; Jac A Nickoloff; Zhiyuan Shen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Functions of nuclear actin-binding proteins in human cancer.

Authors:  Xinyi Yang; Ying Lin
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

7.  Hypoxia-induced and calpain-dependent cleavage of filamin A regulates the hypoxic response.

Authors:  Xiaowei Zheng; Alex-Xianghua Zhou; Pegah Rouhi; Hidetaka Uramoto; Jan Borén; Yihai Cao; Teresa Pereira; Levent M Akyürek; Lorenz Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

8.  Filamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway.

Authors:  Young Joo Jeon; Joon Seok Choi; Jung Yun Lee; Kyung Ryun Yu; Seung Hyeun Ka; Yongcheol Cho; Eui-Ju Choi; Sung Hee Baek; Jae Hong Seol; Dongeun Park; Ok Sun Bang; Chin Ha Chung
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

9.  Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.

Authors:  Jennifer L Fiori; Tie-Nian Zhu; Michael P O'Connell; Keith S Hoek; Fred E Indig; Brittany P Frank; Christa Morris; Sutapa Kole; Joanne Hasskamp; George Elias; Ashani T Weeraratna; Michel Bernier
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

Review 10.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.